AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3924720 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional repletion for an additional 8 days
Number of subjects: 6
Study 3924720 — intervention group
Group type: COMPARATOR
Intervention: Baseline period with 5% dextrose, 440 kcal per day
Number of subjects: 6
Study 31535628 — intervention group
Group type: EXPERIMENTAL
Intervention: Testicular volume measurement
Number of subjects: 89
Study 31535628 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI and LH in multivariable model
Number of subjects: 89
Study 31535628 — intervention group
Group type: EXPERIMENTAL
Intervention: IIEF-5 score
Number of subjects: 89
Study 31535628 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip strength and physical function tests
Number of subjects: 89
Study 31535628 — intervention group
Group type: EXPERIMENTAL
Intervention: AMS score
Number of subjects: 89
Study 30448186 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative method (rotational scarf osteotomy with bone fragment impaction and adductor hallucis tendon reinsertion)
Number of subjects: 78
Study 30448186 — intervention group
Group type: COMPARATOR
Intervention: Standard method (classical scarf osteotomy)
Number of subjects: 78
Study 28803380 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic interval training (AIT)
Number of subjects: 38
Study 28803380 — intervention group
Group type: COMPARATOR
Intervention: Non-training control (CONT)
Number of subjects: 38
Study 26495416 — intervention group
Group type: EXPERIMENTAL
Intervention: R-acupuncture group
Number of subjects: 0
Study 26495416 — intervention group
Group type: EXPERIMENTAL
Intervention: NR-acupuncture group
Number of subjects: 0
Study 26495416 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled-acupuncture group
Number of subjects: 0
Study 26495416 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 23383969 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound with hyaluronidase
Number of subjects: 42
Study 23383969 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound without hyaluronidase
Number of subjects: 42
Study 21729485 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-oriented dietary intervention
Number of subjects: 660
Study 19346114 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine-rich diet (approximately 800 mg/day)
Number of subjects: 8
Study 19346114 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine supplement (0.5 g twice daily)
Number of subjects: 8
Study 19346114 — intervention group
Group type: COMPARATOR
Intervention: Control (pre-treatment values)
Number of subjects: 8
Study 17595426 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Environmental Skill‐Building Program
Number of subjects: 105
Study 15224241 — intervention group
Group type: COMPARATOR
Intervention: Vegetarians
Number of subjects: 10550
Study 15224241 — intervention group
Group type: EXPERIMENTAL
Intervention: General population
Number of subjects: 10550
Study 15224241 — intervention group
Group type: COMPARATOR
Intervention: Young adulthood vegetarians
Number of subjects: 10550
Study 11511429 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 14
Study 11511429 — intervention group
Group type: COMPARATOR
Intervention: Control (no carvedilol)
Number of subjects: 14
Study 9745440 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 12
Study 9745440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7872724 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Chinese hepatitis B carriers
Number of subjects: 78
Study 7872724 — intervention group
Group type: COMPARATOR
Intervention: Normal Chinese individuals
Number of subjects: 78
Study 3323165 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxithromycin 300 mg daily
Number of subjects: 227
Study 3323165 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxithromycin 150 mg bd
Number of subjects: 227
Study 31664782 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Number of subjects: 11
Study 31664782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 30137297 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention in pregnancy with online support; Duration: Not specified; Dosage: Not specified
Number of subjects: 22
Study 30137297 — intervention group
Group type: EXPERIMENTAL
Intervention: Online support; Duration: Not specified; Dosage: Not specified
Number of subjects: 22
Study 29187310 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade III passive lumbar rotational mobilization
Number of subjects: 24
Study 29187310 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 24
Study 26522334 — intervention group
Group type: COMPARATOR
Intervention: 74 Gy in 37 fractions
Number of subjects: 2100
Study 26522334 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 Gy in 20 fractions
Number of subjects: 2100
Study 26522334 — intervention group
Group type: EXPERIMENTAL
Intervention: 57 Gy in 19 fractions
Number of subjects: 2100
Study 24095588 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 LCPUFA supplementation (277.8mg DHA and 39.0mg EPA/capsule)
Number of subjects: 0
Study 24095588 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 LCPUFA supplementation
Number of subjects: 0
Study 24095588 — intervention group
Group type: COMPARATOR
Intervention: Placebo (high oleic acid sunflower seed oil)
Number of subjects: 0
Study 21782381 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxypropyl methylcellulose (HPMC) 2% gel (Cornea_Protect)
Number of subjects: 97
Study 21782381 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (BSS)
Number of subjects: 97
Study 19361739 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg
Number of subjects: 60
Study 19361739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 60
Study 19361739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 17065697 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 1003
Study 17065697 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 1003
Study 17065697 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training
Number of subjects: 1003
Study 17065697 — intervention group
Group type: COMPARATOR
Intervention: Dietary, drug, and insulin treatments
Number of subjects: 1003
Study 15079008 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis extract (oral cannador)
Number of subjects: 14
Study 15079008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 15079008 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis extract
Number of subjects: 14
Study 14512073 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrollment in an intervention trial
Number of subjects: 2280
Study 10721462 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitization (group 1)
Number of subjects: 73
Study 10721462 — intervention group
Group type: COMPARATOR
Intervention: Rechallenge (group 2)
Number of subjects: 73
Study 8933491 — intervention group
Group type: EXPERIMENTAL
Intervention: Countermovement Jump (CMJ)
Number of subjects: 6
Study 8933491 — intervention group
Group type: COMPARATOR
Intervention: Squat Jump (SJ)
Number of subjects: 6
Study 1599856 — intervention group
Group type: EXPERIMENTAL
Intervention: Role of clinical coordinator in managing patient follow-up
Number of subjects: 0
Study 3890223 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosaramicin
Number of subjects: 39
Study 3890223 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin plus probenecid
Number of subjects: 39
Study 30471974 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational patient hand hygiene intervention
Number of subjects: 0
Study 30471974 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 29506017 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral Support Actions (RSA) for RA
Number of subjects: 571
Study 29506017 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention) for RA
Number of subjects: 571
Study 29506017 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral Support Actions (RSA) for axial SpA
Number of subjects: 571
Study 29506017 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention) for axial SpA
Number of subjects: 571
Study 27096673 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung hyperinflation by mechanical ventilator (MVH Group)
Number of subjects: 50
Study 27096673 — intervention group
Group type: COMPARATOR
Intervention: Isolated tracheal aspiration (Control Group)
Number of subjects: 50
Study 24794837 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading (magazine or electronic device)
Number of subjects: 65
Study 24794837 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to self‐selected relaxing music
Number of subjects: 65
Study 24794837 — intervention group
Group type: COMPARATOR
Intervention: Resting
Number of subjects: 65
Study 22092547 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK clips
Number of subjects: 30
Study 22092547 — intervention group
Group type: COMPARATOR
Intervention: POM clips
Number of subjects: 30
Study 22092547 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PEEK and POM clips
Number of subjects: 30
Study 22092547 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention force over time
Number of subjects: 30
Study 19883386 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program aimed at preventing groin injuries (n=27 clubs)
Number of subjects: 1211
Study 19883386 — intervention group
Group type: COMPARATOR
Intervention: Control group training as usual (n=28 clubs)
Number of subjects: 1211
Study 19030136 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate and electrolytes (CHO)
Number of subjects: 9
Study 19030136 — intervention group
Group type: COMPARATOR
Intervention: Flavored-water placebo with electrolytes (PLA)
Number of subjects: 9
Study 16477089 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐amphetamine
Number of subjects: 31
Study 16477089 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 31
Study 12032647 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet S (stearic acid enriched)
Number of subjects: 9
Study 12032647 — intervention group
Group type: COMPARATOR
Intervention: Diet P (palmitic acid enriched)
Number of subjects: 9
Study 12032647 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet S
Number of subjects: 9
Study 12032647 — intervention group
Group type: COMPARATOR
Intervention: Diet P
Number of subjects: 9
Study 10075068 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (1 microg/kg bolus followed by 0.005 microg/kg/min infusion)
Number of subjects: 6
Study 10075068 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (10 microg/kg bolus followed by 0.075 microg/kg/min infusion)
Number of subjects: 6
Study 10075068 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (100 microg/kg bolus followed by 0.7 microg/kg/min infusion)
Number of subjects: 6
Study 10150534 — intervention group
Group type: EXPERIMENTAL
Intervention: LEP (Mail-delivered, self-instructional exercise packets)
Number of subjects: 0
Study 10150534 — intervention group
Group type: EXPERIMENTAL
Intervention: FFP (Another form of exercise packet)
Number of subjects: 0
Study 10150534 — intervention group
Group type: COMPARATOR
Intervention: SEP (Standard exercise packet)
Number of subjects: 0
Study 10150534 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (combined)
Number of subjects: 0
Study 1828366 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil with continuous epidural infusion of 0.125% bupivacaine
Number of subjects: 28
Study 1828366 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sufentanil with continuous intravenous infusion of 0.125% bupivacaine
Number of subjects: 28
Study 6785099 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenously infused saralasin (dose 0.01‐10 microgram kg‐1 min‐1)
Number of subjects: 0
Study 6785099 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of saralasin at the highest dose directly into the renal artery of denervated kidneys
Number of subjects: 0
Study 31586293 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (MMI) 10 mg for 6 weeks prior to 131I therapy
Number of subjects: 31
Study 31586293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 31369674 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 46
Study 31369674 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 46
Study 28647384 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoid unhealthy food/approach healthy food training
Number of subjects: 200
Study 28647384 — intervention group
Group type: COMPARATOR
Intervention: Other conditions (not specified)
Number of subjects: 200
Study 25841622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS)
Number of subjects: 148
Study 25841622 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine (PC)
Number of subjects: 148
Study 23783643 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ofloxacin (200 mg) and roxithromycin (150 mg) twice daily for 3 months
Number of subjects: 56
Study 23783643 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 56
Study 23783643 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ofloxacin and roxithromycin
Number of subjects: 56
Study 23783643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 20957498 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg once daily
Number of subjects: 329
Study 20957498 — intervention group
Group type: COMPARATOR
Intervention: mosapride 5 mg thrice daily
Number of subjects: 329
Study 19564557 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated depression symptoms (Beck Depression Inventory‐II >or=14)
Number of subjects: 974
Study 19564557 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmarried status in depressed patients
Number of subjects: 974
Study 16928807 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 2231
Study 16928807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2231
Study 16928807 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Captopril and Placebo)
Number of subjects: 2231
Study 14722778 — intervention group
Group type: EXPERIMENTAL
Intervention: Biering‐Sorensen muscle endurance (BSME) test using near infrared spectroscopy (NIRS)
Number of subjects: 17
Study 11473681 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide 0.5 mg twice daily for 1 month followed by 0.25 mg daily for the next 2 months
Number of subjects: 49
Study 11473681 — intervention group
Group type: COMPARATOR
Intervention: Nebulized budesonide 0.1 mg twice daily throughout the 3-month treatment period
Number of subjects: 49
Study 11473681 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (high-dose and low-dose)
Number of subjects: 49
Study 9440663 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis for PCP and toxoplasmosis with trimethoprim‐sulfamethoxazole
Number of subjects: 0
Study 9440663 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis for MAC with azithromycin
Number of subjects: 0
Study 9440663 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis for MAC with rifabutin
Number of subjects: 0
Study 9440663 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ganciclovir for the prevention of CMV infection
Number of subjects: 0
Study 9440663 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study 8299805 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 8
Study 8299805 — intervention group
Group type: COMPARATOR
Intervention: Intracervical insemination
Number of subjects: 8
Study 3263868 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 400 micrograms
Number of subjects: 35
Study 3263868 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 100 micrograms
Number of subjects: 35
Study 3263868 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 200 micrograms
Number of subjects: 35
Study 3263868 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 200 micrograms (multiple 5 day administration)
Number of subjects: 35
Study 3263868 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) (high-dose group)
Number of subjects: 35
Study 5297559 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine (for negative reactors)
Number of subjects: 1099
Study 5297559 — intervention group
Group type: EXPERIMENTAL
Intervention: Smallpox vaccine
Number of subjects: 1099
Study 5297559 — intervention group
Group type: EXPERIMENTAL
Intervention: Smallpox vaccine with BCG for negative reactors
Number of subjects: 1099
Study 5297559 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 1099
Study 83108 — intervention group
Group type: EXPERIMENTAL
Intervention: Slide-tape program with pharmacist present (Group 1)
Number of subjects: 34
Study 83108 — intervention group
Group type: COMPARATOR
Intervention: Slide-tape program without pharmacist present (Group 2)
Number of subjects: 34
Study 31898768 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 36
Study 31898768 — intervention group
Group type: COMPARATOR
Intervention: Body acupuncture (BA)
Number of subjects: 36
Study 31296568 — intervention group
Group type: EXPERIMENTAL
Intervention: CHAT (brief motivational intervention)
Number of subjects: 294
Study 31296568 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 294
Study 30093799 — intervention group
Group type: EXPERIMENTAL
Intervention: Resonance Voice Therapy (RVT)
Number of subjects: 20
Study 30093799 — intervention group
Group type: COMPARATOR
Intervention: Cervical-thoracic therapy
Number of subjects: 20
Study 27121901 — intervention group
Group type: EXPERIMENTAL
Intervention: PP-501-B
Number of subjects: 81
Study 27121901 — intervention group
Group type: COMPARATOR
Intervention: Restylane Perlane
Number of subjects: 81
Study 27121901 — intervention group
Group type: EXPERIMENTAL
Intervention: PP-501-B and Restylane Perlane
Number of subjects: 81
Study 25013367 — intervention group
Group type: EXPERIMENTAL
Intervention: Chuanhu anti-gout mixture
Number of subjects: 176
Study 25013367 — intervention group
Group type: COMPARATOR
Intervention: Colchicine
Number of subjects: 176
Study 23060319 — intervention group
Group type: COMPARATOR
Intervention: SPC(2+6) design
Number of subjects: 51
Study 23060319 — intervention group
Group type: COMPARATOR
Intervention: SPC(4+4) design
Number of subjects: 51
Study 23060319 — intervention group
Group type: COMPARATOR
Intervention: SPC designs (SPC(2+6), SPC(4+4), SPC(6+6))
Number of subjects: 51
Study 19914051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg IV (Group D; n = 30)
Number of subjects: 60
Study 19914051 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group S; n = 30)
Number of subjects: 60
Study 17804333 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketac‐Cem (3M ESPE, St Paul, MN)
Number of subjects: 55
Study 17804333 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond/Clearfil AP‐X (Kuraray, New York, NY)
Number of subjects: 55
Study 17804333 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxcem (Kerr, Orange, CA)
Number of subjects: 55
Study 17804333 — intervention group
Group type: COMPARATOR
Intervention: Negative control group (n = 5)
Number of subjects: 55
Study 17804333 — intervention group
Group type: COMPARATOR
Intervention: Positive control group (n = 5)
Number of subjects: 55
Study 12690049 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine-6-beta-glucuronide (M6G) infusion (low dose, 2 hours)
Number of subjects: 0
Study 12690049 — intervention group
Group type: COMPARATOR
Intervention: Morphine infusion (positive control)
Number of subjects: 0
Study 10743458 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia with clinical signs monitoring
Number of subjects: 30
Study 10743458 — intervention group
Group type: COMPARATOR
Intervention: Propofol anaesthesia with EEG threshold method
Number of subjects: 30
Study 8770484 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthesia infusion sleeve (AIS)
Number of subjects: 20
Study 8770484 — intervention group
Group type: COMPARATOR
Intervention: Standard sheath
Number of subjects: 20
Study 1345035 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2 g per day)
Number of subjects: 0
Study 1345035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3160209 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 203
Study 3160209 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl/Droperidol
Number of subjects: 203
Study 3160209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 31138316 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued SDZ ETN (50 mg subcutaneous once-weekly)
Number of subjects: 279
Study 31138316 — intervention group
Group type: COMPARATOR
Intervention: Switched to SDZ ETN (50 mg subcutaneous once-weekly)
Number of subjects: 279
Study 31138316 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued SDZ ETN
Number of subjects: 279
Study 31138316 — intervention group
Group type: COMPARATOR
Intervention: Switched to SDZ ETN
Number of subjects: 279
Study 31138316 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 279
Study 27176631 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with clonidine (15 μg mL-1)
Number of subjects: 100
Study 27176631 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine with epinephrine (12.5 μg mL-1)
Number of subjects: 100
Study 25461825 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mA a‐tDCS
Number of subjects: 9
Study 25461825 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mA a‐tDCS
Number of subjects: 9
Study 25461825 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 9
Study 23949563 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume morning-only polyethylene glycol with specially designed test meals (LV-PEG with TM)
Number of subjects: 197